Evaluation of the Corrected QT Interval with Bazett's Method in Cavalier King Charles Spaniel Dogs with Myxomatous Mitral Valve Disease

被引:0
|
作者
Sagoglu, Hande [1 ]
Gonul, Remzi [1 ,2 ]
Koenhemsi, Lora [1 ]
Alan, Emine Merve [1 ]
Murat, Suzan [1 ]
Nia, Ashkan Seddigh [1 ]
Or, Mehmet Erman [1 ]
机构
[1] Istanbul Univ Cerrahpasa, Fac Vet Med, Dept Internal Med, Istanbul 34320, Turkiye
[2] Istanbul Univ Cerrahpasa, Fac Vet Med, Dept Internal Med, TR-34320 Istanbul, Turkiye
关键词
Cavalier; myxomatous; mitral valve; QT; PROLONGATION; IDENTIFICATION; APPROPRIATE; FORMULAS; SIZE;
D O I
10.2478/macvetrev-2023-0014
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Myxomatous mitral valve disease (MMVD) is one of the most common heart diseases in dogs. The disease progresses faster in Cavalier King Charles Spaniel (CKCS) dogs and occurs at an earlier age. QT interval length reflects abnormalities in ventricular repolarization which may predispose to the formation of fatal arrhythmias such as torsades de pointes. A fast and accurate assessment is therefore essential. The study aimed to examine the changes in QT duration in MMVD cases of CKCS and to calculate the corrected QT durations with Bazett's formula in various stages of the disease. The study included 20 CKCS dogs of both genders, various ages and weights, and different stages of MMVD (n=6 in B1 stage, n=6 in B2 stage, and n=8 in C stage), and 5 healthy CKCS which were included in the control group. Clinical, radiological, hematological, biochemical, echocardiographic, and electrocardiographic examinations were performed. The corrected QT interval duration in the MMVD group was longer than the control (p < 0.05). However, there was no significant difference between B1, B2, and C. It was concluded that the corrected QT interval can give a significant distinction between healthy and MMVD CKCS dogs.
引用
收藏
页码:61 / 67
页数:7
相关论文
共 50 条
  • [21] Evaluation of genes associated with human myxomatous mitral valve disease in dogs with familial myxomatous mitral valve degeneration
    Meurs, K. M.
    Friedenberg, S. G.
    Williams, B.
    Keene, B. W.
    Atkins, C. E.
    Adin, D.
    Aona, B.
    DeFrancesco, T.
    Tou, S.
    Mackay, T.
    VETERINARY JOURNAL, 2018, 232 : 16 - 19
  • [22] Screening methods for mitral valve degeneration and breeding protocol in the cavalier King Charles spaniel: a survey amongst breeders and veterinarians
    Celis, N.
    Liekens, V.
    Hellemans, A.
    Smets, P.
    VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT, 2024, 93 (02): : 91 - 98
  • [23] Genome-wide analysis of mitral valve disease in Cavalier King Charles Spaniels
    French, Anne T.
    Ogden, Rob
    Eland, Cathlene
    Hemani, Gibran
    Pong-Wong, Ricardo
    Corcoran, Brendan
    Summers, Kim M.
    VETERINARY JOURNAL, 2012, 193 (01): : 283 - 286
  • [24] Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease
    Cremer, Signe E.
    Kristensen, Annemarie T.
    Reimann, Maria J.
    Eriksen, Nynne B.
    Petersen, Stine F.
    Marschner, Clara B.
    Tarnow, Inge
    Oyama, Mark A.
    Olsen, Lisbeth H.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2015, 76 (06) : 520 - 531
  • [25] Depleted Myocardial Coenzyme Q10 in Cavalier King Charles Spaniels with Congestive Heart Failure Due to Myxomatous Mitral Valve Disease
    Christiansen, Liselotte B.
    Reimann, Maria J.
    Schou-Pedersen, Anne Marie V.
    Larsen, Steen
    Lykkesfeldt, Jens
    Olsen, Lisbeth H.
    ANTIOXIDANTS, 2021, 10 (02) : 1 - 13
  • [26] Mitral valve transcriptome analysis in thirty-four age-matched Cavalier King Charles Spaniels with or without congestive heart failure caused by myxomatous mitral valve disease
    Reimann, Maria J.
    Cremer, Signe
    Christiansen, Liselotte
    Ibragimov, Emil
    Gao, Fei
    Cirera, Susanna
    Fredholm, Merete
    Olsen, Lisbeth H.
    Karlskov-Mortensen, Peter
    MAMMALIAN GENOME, 2024, 35 (01) : 77 - 89
  • [27] Mitral valve transcriptome analysis in thirty-four age-matched Cavalier King Charles Spaniels with or without congestive heart failure caused by myxomatous mitral valve disease
    Maria J. Reimann
    Signe Cremer
    Liselotte Christiansen
    Emil Ibragimov
    Fei Gao
    Susanna Cirera
    Merete Fredholm
    Lisbeth H. Olsen
    Peter Karlskov-Mortensen
    Mammalian Genome, 2024, 35 : 77 - 89
  • [28] Pharmacoeconomic evaluation of the treatment of myxomatous mitral valve disease in dogs in Germany
    Nautrup, Barbara Poulsen
    Van Vlaenderen, Ilse
    Nautrup, Cordula Poulsen
    KLEINTIERPRAXIS, 2010, 55 (04): : 184 - +
  • [29] Evaluation of progression of chronic kidney disease in dogs with myxomatous mitral valve disease
    Yun, Hyejin
    Koo, Yoonhoi
    Yun, Taesik
    Chae, Yeon
    Lee, Dohee
    Cha, Sijin
    Kim, Jeeyune
    Kim, Hakhyun
    Yang, Mhan Pyo
    Kang, Byeong Teck
    FRONTIERS IN VETERINARY SCIENCE, 2023, 10
  • [30] Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease
    Eriksson, Anders S.
    Haggstrom, Jens
    Pedersen, Henrik Duelund
    Hansson, Kerstin
    Jarvinen, Anna-Kaisa
    Haukka, Jari
    Kvart, Clarence
    JOURNAL OF VETERINARY CARDIOLOGY, 2014, 16 (03) : 141 - 154